[
    "{\"step_by_step_thinking\": \"Based on the information provided in the documents, LB-100 has been tested in clinical trials. Document [0] mentions the first phase I trial (NCT01837667) evaluating LB-100, and Document [1] describes a phase I trial of LB-100 in patients with relapsed solid tumors. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]